NODB Stock News 58.5000 05/08/2014 16:34:36 North Dallas BK&Tr

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
North Dallas BK&Tr Co Tex (NODB) 58.5000 $NODB

North Dallas Bank & Trust Co. Announces First Quarter Earnings of $0.56 per Share
Marketwire - Mon Apr 14, 9:44AM CDT
North Dallas Bank & Trust Co. (OTCBB: NODB) announces net earnings of $1,429,039 or $0.56 per share for the three months ending March 31, 2014, compared to $1,028,274 or $0.40 per share for the same period in 2013.

North Dallas Bank & Trust Co. Declares Regular Dividend of $0.17 per Share
Marketwire - Wed Mar 19, 9:46AM CDT
On March 18, 2014 the North Dallas Bank & Trust Co. (OTCBB: NODB) Board of Directors declared a regular dividend of $0.17 per share. The dividend is payable to shareholders of record as of April 10, 2014 and will be paid on April 14, 2014.

North Dallas Bank & Trust Co. Announces Fourth Quarter Earnings of $0.68 per Share
Marketwire - Tue Jan 14, 11:04AM CST
North Dallas Bank & Trust Co. (OTCBB: NODB) announces net earnings of $1,743,446 or $0.68 per share for the three months ending December 31, 2013, compared to $1,481,209 or $0.58 per share for the same period in 2012. Net earnings for the year ending December 31, 2013 totaled $5,593,441 or $2.18 per share compared to $5,881,545 or $2.28 per share in 2012. The annual shareholders' meeting is scheduled for February 4, 2014 in Dallas, Texas.

North Dallas Bank & Trust Co. Declares 2013 Special Dividend
Marketwire - Thu Dec 12, 9:31AM CST
On December 10, 2013 the Board of Directors of North Dallas Bank & Trust Co. (OTCBB: NODB) declared a special dividend in the amount of $0.10 per share.

North Dallas Bank & Trust Co. Announces Second Quarter Earnings of $0.47 per Share
Marketwire - Fri Jul 19, 9:03AM CDT
North Dallas Bank & Trust Co. (OTCBB: NODB) announces net earnings of $1,211,048 or $0.47 per share for the three months ending June 30, 2013, compared to $1,446,161 or $0.56 per share for the same period in 2012. Year to date net earnings through the six months ending June 30, 2013 totaled $2,239,322 or $0.87 per share compared to $2,998,829 or $1.17 per share for the same period in 2012.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Discovering Innovation: Smitty's Car Wash on Public Television

Updated Category News Views 332

Innovation at Smitty's Car Wash Viewers are in for an enlightening experience as the show "Empowered with Meg Ryan" spotlights Smitty's Car Wash, a pioneer in the express tunnel car wash industry. This segment promises to challenge traditional notions of car washing, showcasing how modern methods and technology integrate to create not just services, but transformative...

Continue Reading
ASPCA® Expands Veterinary Services with New Clinic Opening

Updated Category News Views 144

ASPCA® Opens New Community Veterinary Clinic in New York The ASPCA Community Veterinary Clinic, supported by The Rachael Ray Foundation, is set to meet the needs of many pets in the local area. This opening in New York City is a crucial advancement in providing vital veterinary care to communities in need. Veterinary Services That Are Within Reach Thousands of pets in...

Continue Reading
Big Boost for European Innovation with Novo Nordisk Foundation's Grant

Updated Category News Views 91

Novo Nordisk Foundation Boosts Innovation Funding In a groundbreaking move to enhance innovation in Europe, the Novo Nordisk Foundation is investing up to DKK 5.5 billion (approximately EUR 736 million) into the BioInnovation Institute (BII). This funding is set to play a transformative role in supporting entrepreneurs and startups within the life sciences sector....

Continue Reading
Legal Challenges for 3D Systems: Investor Action Recommended

Updated Category News Views 165

Overview of the Legal Situation Recent events surrounding 3D Systems Corporation have raised significant concerns among investors. The company is currently facing a class action lawsuit that alleges violations of securities laws. Investors in 3D Systems are encouraged to stay informed about the progress of this legal challenge and consider their options moving forward....

Continue Reading
Inhibikase Therapeutics Updates: Q2 2025 Financial Overview

Updated Category News Views 135

Inhibikase Therapeutics Q2 2025 Financial Update Inhibikase Therapeutics, Inc. (NASDAQ: IKT) is making notable strides as a clinical-stage pharmaceutical company dedicated to developing innovative therapeutics aimed at addressing cardiopulmonary diseases, particularly Pulmonary Arterial Hypertension (PAH). Recently, they announced their financial results for the second...

Continue Reading